These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9718282)

  • 41. Nimodipine reduction of naltrexone-precipitated locus coeruleus activation and abstinence behavior in morphine-dependent rats.
    Krystal JH; Compere S; Nestler EJ; Rasmussen K
    Physiol Behav; 1996; 59(4-5):863-6. PubMed ID: 8778878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opiate withdrawal induces Narp in the extended amygdala.
    Reti IM; Baraban JM
    Neuropsychopharmacology; 2003 Sep; 28(9):1606-13. PubMed ID: 12784103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.
    Rasmussen K; Fuller RW; Stockton ME; Perry KW; Swinford RM; Ornstein PL
    Eur J Pharmacol; 1991 May; 197(1):9-16. PubMed ID: 1832640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion.
    Gracy KN; Dankiewicz LA; Koob GF
    Neuropsychopharmacology; 2001 Feb; 24(2):152-60. PubMed ID: 11120397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates.
    Roth RH; Elsworth JD; Redmond DE
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):42-6. PubMed ID: 6806253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat.
    Zhang T; Feng Y; Rockhold RW; Ho IK
    Life Sci; 1994; 55(2):PL25-31. PubMed ID: 7912397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of two alpha-noradrenergic agonists (clonidine and guanfacine) on norepinephrine turnover in the cortex of rats during morphine abstinence.
    Zigun JR; Bannon MJ; Roth RH
    Eur J Pharmacol; 1981 Apr; 70(4):565-70. PubMed ID: 6113150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ethanol attenuation of morphine dependence: comparison to dizocilpine.
    Shoemaker WJ; Kosten TA; Muly SM
    Psychopharmacology (Berl); 1997 Nov; 134(1):83-7. PubMed ID: 9399370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
    Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
    Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebral glucose metabolism during opioid withdrawal following methylnaloxonium injection into the locus coeruleus.
    Kimes AS; Maldonado R; Ambrosio E; Koob GF; London ED
    Brain Res; 1998 Dec; 814(1-2):1-12. PubMed ID: 9838021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal.
    Kimes AS; Bell JA; London ED
    Neuroscience; 1990; 34(3):633-44. PubMed ID: 2352645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.
    Frenois F; Cador M; Caillé S; Stinus L; Le Moine C
    Eur J Neurosci; 2002 Oct; 16(7):1377-89. PubMed ID: 12405997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal.
    Kosten TA
    Eur J Pharmacol; 1994 Mar; 254(1-2):59-63. PubMed ID: 8206117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clonidine attenuates naloxone-induced opioid-withdrawal syndrome in cholestatic mice.
    Dehpour AR; Samini M; Arad MA; Namiranian K
    Pharmacol Toxicol; 2001 Sep; 89(3):129-32. PubMed ID: 11589783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
    Sullivan ME; Hall SR; Milne B; Jhamandas K
    Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Naloxone alters the local metabolic rate for glucose in discrete brain regions associated with opiate withdrawal.
    Kraus MA; Piper JM; Kornetsky C
    Brain Res; 1996 Jun; 724(1):33-40. PubMed ID: 8816253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine.
    Jhamandas KH; Marsala M; Ibuki T; Yaksh TL
    J Neurosci; 1996 Apr; 16(8):2758-66. PubMed ID: 8786451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of gene transfer of GLT-1, a glutamate transporter, into the locus coeruleus by recombinant adenoviruses on morphine physical dependence in rats.
    Ozawa T; Nakagawa T; Sekiya Y; Minami M; Satoh M
    Eur J Neurosci; 2004 Jan; 19(1):221-6. PubMed ID: 14750980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion.
    Delfs JM; Zhu Y; Druhan JP; Aston-Jones G
    Nature; 2000 Jan; 403(6768):430-4. PubMed ID: 10667795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behavior of monkeys during opiate withdrawal and locus coeruleus stimulation.
    Grant SJ; Huang YH; Redmond DE
    Pharmacol Biochem Behav; 1988 May; 30(1):13-9. PubMed ID: 3174735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.